A phase II study of dasatinib and dexamethasone as primary therapy followed by transplantation for adults with newly diagnosed PH/BCR-ABL1-positive acute lymphoblastic leukemia: Final results of Alliance/CALGB study 10701
   Google Scholar   
Citation:
Blood vol 132 (suppl 1) abstr 309
Meeting Instance:
ASH 2018
Year:
2018
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3410  
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA180861, U24CA196171, U10CA180820, U10CA180888  
Corr. Author:
 
Authors:
                               
Networks:
IL017, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-OH007, LAPS-PA015, LAPS-WI020, NC002, NORTHWELL   
Study
CALGB-10701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: